Meconium aspiration syndrome
diseaseOn this page
Also known as aspiration syndrome, meconiumaspiration, meconiumMASmeconium aspirationmeconium inhalationneonatal aspiration of meconiumsyndrome, meconium aspiration
Summary
Meconium aspiration syndrome (MONDO:0006851) is a disease and 19 clinical trials. Top therapeutic interventions include sildenafil, caffeine citrate, and emapalumab. A subtype of neonatal aspiration syndrome — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: 1-9 / 100 000 (Europe) [Orphanet-validated]
- Phenotypes (HPO): 22
- Clinical trials: 19
Clinical features
Epidemiology
Prevalence records
1 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Point prevalence | 1-9 / 100 000 | 2.44 | Europe | Validated |
Signs & symptoms
Clinical features (HPO)
22 HPO clinical features (Orphanet curated; top 22 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0002098 | Respiratory distress | Frequent (30-79%) |
| HP:0005828 | Transient pulmonary infiltrates | Frequent (30-79%) |
| HP:0011410 | Caesarian section | Frequent (30-79%) |
| HP:0025116 | Fetal distress | Frequent (30-79%) |
| HP:0031169 | Postterm pregnancy | Frequent (30-79%) |
| HP:0031860 | Abnormal heart rate variability | Frequent (30-79%) |
| HP:0031983 | Abnormal pulmonary thoracic imaging finding | Frequent (30-79%) |
| HP:0001511 | Intrauterine growth retardation | Occasional (5-29%) |
| HP:0001788 | Premature rupture of membranes | Occasional (5-29%) |
| HP:0002092 | Pulmonary arterial hypertension | Occasional (5-29%) |
| HP:0002107 | Pneumothorax | Occasional (5-29%) |
| HP:0008071 | Maternal hypertension | Occasional (5-29%) |
| HP:0009800 | Maternal diabetes | Occasional (5-29%) |
| HP:0011951 | Aspiration pneumonia | Occasional (5-29%) |
| HP:0012418 | Hypoxemia | Occasional (5-29%) |
| HP:0012420 | Meconium stained amniotic fluid | Occasional (5-29%) |
| HP:0012768 | Neonatal asphyxia | Occasional (5-29%) |
| HP:0025421 | Pneumomediastinum | Occasional (5-29%) |
| HP:0030828 | Wheezing | Occasional (5-29%) |
| HP:0100750 | Atelectasis | Occasional (5-29%) |
| HP:0001298 | Encephalopathy | Very rare (<1-4%) |
| HP:0010444 | Pulmonary insufficiency | Very rare (<1-4%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | meconium aspiration syndrome |
| Mondo ID | MONDO:0006851 |
| EFO | EFO:1001037 |
| MeSH | D008471 |
| Orphanet | 70588 |
| DOID | DOID:11049 |
| ICD-10-CM | P24.0 |
| ICD-11 | 872221482 |
| NCIT | C87093 |
| SNOMED CT | 206292002 |
| UMLS | C0025048 |
| MedGen | 6258 |
| GARD | 0010494 |
| MedDRA | 10027057 |
| Is cancer (heuristic) | no |
Also known as: aspiration syndrome, meconium · aspiration, meconium · MAS · meconium aspiration · meconium aspiration syndrome · meconium inhalation · neonatal aspiration of meconium · syndrome, meconium aspiration
Disease family
This is a subtype of neonatal aspiration syndrome. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › syndromic disease › neonatal aspiration syndrome › meconium aspiration syndrome
Related subtypes (1): massive neonatal aspiration syndrome
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
Drugs indicated for this disease
0 approved, 1 in late-stage (phase 3) trials. Disease-direct ChEMBL indications, not inferred from the associated-gene cohort below.
| Drug | Development status |
|---|---|
| Lucinactant | Phase 3 (in late-stage trials) |
Clinical trials & evidence
Clinical trials
Clinical trials: 19.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 13 |
| PHASE3 | 3 |
| PHASE4 | 2 |
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01757782 | PHASE4 | COMPLETED | Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns |
| NCT02041546 | PHASE4 | COMPLETED | Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration Syndrome |
| NCT00004500 | PHASE3 | TERMINATED | Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome |
| NCT00312507 | PHASE3 | UNKNOWN | Surfactant Lavage vs. Bolus Surfactant in Neonates With Meconium Aspiration |
| NCT05001737 | PHASE3 | COMPLETED | Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still’s or SLE |
| NCT06972108 | PHASE2 | NOT_YET_RECRUITING | CAffeine Use in Prolonged Oxygen Use in meConium aspIration Syndrome in Neonatal Outcomes (CAPUCINO) |
| NCT03346343 | Not specified | ACTIVE_NOT_RECRUITING | Pulmonary Function Using Non-invasive Forced Oscillometry |
| NCT07344714 | Not specified | RECRUITING | Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting |
| NCT00371241 | Not specified | COMPLETED | Antibody Secreting Cell and Cyotokine Profiles in Neonates on ECMO |
| NCT01274845 | Not specified | COMPLETED | Use of Heliox in the Management of Neonates With Meconium Aspiration Syndrome |
| NCT01310621 | Not specified | COMPLETED | Comparison Of Surfactant Lung Lavage With Standard Care In The Treatment Of Meconium Aspiration Syndrome |
| NCT01328483 | Not specified | COMPLETED | Effect Of Intrapartum Oropharyngeal (IP-OP) Suction on Meconium Aspiration Syndrome |
| NCT01758822 | Not specified | COMPLETED | Role of Endotracheal Suction on the Occurrence of Meconium Aspiration Syndrome in Non-vigorous Meconium Stained Babies |
| NCT02571231 | Not specified | UNKNOWN | High Flow Ventilation With Volume Guarantee |
| NCT02708563 | Not specified | WITHDRAWN | Meconium Aspiration and Tracheal Suctioning-Feasibility Study |
| NCT03996317 | Not specified | WITHDRAWN | Maternal Hyperoxygenation for Intrapartum Fetal Heart Rate Tracing Abnormalities |
| NCT04076189 | Not specified | COMPLETED | Time of Positive Pressure Ventilation in Non-vigorous Infants Born Through Meconium-stained Amniotic Fluid |
| NCT06090981 | Not specified | COMPLETED | Early Bolus Surfactant Replacement Therapy Versus Standard Care in Term Neonates With Meconium Aspiration Syndrome |
| NCT07394322 | Not specified | COMPLETED | Interleukin-6 in the Development of Meconium Aspiration Syndrome in Newborn |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| SILDENAFIL | 4 | 3 |
| CAFFEINE CITRATE | 4 | 1 |
| EMAPALUMAB | 4 | 1 |
| LUCINACTANT | 4 | 1 |
Related Atlas pages
- Drugs: Sildenafil, Caffeine, Emapalumab, Lucinactant